181 related articles for article (PubMed ID: 37665353)
1. Collagenase clostridium histolyticum injection versus limited fasciectomy for the treatment of Dupuytren's disease: a systematic review and meta-analysis of comparative studies.
Liechti R; Merky DN; Sutter D; Ipaktchi R; Vögelin E
Arch Orthop Trauma Surg; 2024 Jan; 144(1):527-536. PubMed ID: 37665353
[TBL] [Abstract][Full Text] [Related]
2. Dupuytren's Contracture Recurrence and Treatment Following Collagenase Clostridium Histolyticum Injection: A Longitudinal Assessment in a Veteran Population.
Zarb RM; Graf AR; Talhelm JE; Stehr RC; Sanger JR; Matloub HS; Daley RA
Mil Med; 2023 Aug; 188(9-10):e2975-e2981. PubMed ID: 36928340
[TBL] [Abstract][Full Text] [Related]
3. Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients.
Leclère FM; Kohl S; Varonier C; Unglaub F; Vögelin E
Arch Orthop Trauma Surg; 2018 Nov; 138(11):1623-1631. PubMed ID: 30259125
[TBL] [Abstract][Full Text] [Related]
4. The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren's contracture management: A meta-analysis.
Cooper TB; Poonit K; Yao C; Jin Z; Zheng J; Yan H
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020921747. PubMed ID: 32484064
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren's contracture.
Peimer CA; Wilbrand S; Gerber RA; Chapman D; Szczypa PP
J Hand Surg Eur Vol; 2015 Feb; 40(2):141-9. PubMed ID: 24698851
[TBL] [Abstract][Full Text] [Related]
6. Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation.
Brazzelli M; Cruickshank M; Tassie E; McNamee P; Robertson C; Elders A; Fraser C; Hernandez R; Lawrie D; Ramsay C
Health Technol Assess; 2015 Oct; 19(90):1-202. PubMed ID: 26524616
[TBL] [Abstract][Full Text] [Related]
7. Short-term efficacy and adverse effects of collagenase clostridium histolyticum injections, percutaneous needle fasciotomy and limited fasciectomy in the treatment of Dupuytren's contracture: a network meta-analysis of randomized controlled trials.
Obed D; Salim M; Schlottmann F; Bingoel AS; Panayi AC; Dastagir K; Vogt PM; Koenneker S
BMC Musculoskelet Disord; 2022 Oct; 23(1):939. PubMed ID: 36307837
[TBL] [Abstract][Full Text] [Related]
8. Comparing Complications and Patient Satisfaction Following Injectable Collagenase Versus Limited Fasciectomy for Dupuytren's Disease: A Systematic Review and Meta-Analysis.
Alhebshi ZA; Bamuqabel AO; Alqurain Z; Dahlan D; Wasaya HI; Al Saedi ZS; Alqarni GS; Alqarni D; Ghalimah B
Cureus; 2024 Jan; 16(1):e53147. PubMed ID: 38420076
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Dupuytren's disease after fasciectomy and collagenase injection are histologically indistinguishable.
Sanjuan-Cervero R; Carrera-Hueso FJ; Vaquero-Perez M; Montaner-Alonso D
J Hand Surg Eur Vol; 2020 Jun; 45(5):508-512. PubMed ID: 31980000
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and adverse effects of collagenase use in the treatment of Dupuytren's disease: a meta-analysis.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Ramon-Barrios MA
Bone Joint J; 2018 Jan; 100-B(1):73-80. PubMed ID: 29305454
[TBL] [Abstract][Full Text] [Related]
11. Long-term recurrence of Dupuytren's disease treated with clostridium histolitycum collagenase. Surgical treatment and anatomopathological study.
Simón-Pérez C; Rodríguez-Mateos JI; Maestro IA; Alvarez-Quiñones M; Simon-Perez E; Martín-Ferrero MA
Arch Orthop Trauma Surg; 2024 May; 144(5):2085-2091. PubMed ID: 38653835
[TBL] [Abstract][Full Text] [Related]
12. Limited Fasciectomy Versus Collagenase Clostridium histolyticum for Dupuytren Contracture: A Propensity Score Matched Study of Single Digit Treatment With Minimum 5 Years of Telephone Follow-Up.
Gruber JS; Zhang D; Janssen SJ; Blazar P; Jupiter JB; Earp BE
J Hand Surg Am; 2021 Oct; 46(10):888-895. PubMed ID: 34275684
[TBL] [Abstract][Full Text] [Related]
13. Dupuytren's interventions surgery versus collagenase (DISC) trial: study protocol for a pragmatic, two-arm parallel-group, non-inferiority randomised controlled trial.
Dias J; Arundel C; Tharmanathan P; Keding A; Welch C; Corbacho B; Armaou M; Leighton P; Bainbridge C; Craigen M; Flett L; Gascoyne S; Hewitt C; James E; James S; Johnson N; Jones J; Knowlson C; Radia P; Torgerson D; Warwick D; Watson M
Trials; 2021 Sep; 22(1):671. PubMed ID: 34593024
[TBL] [Abstract][Full Text] [Related]
14. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
Smeraglia F; Del Buono A; Maffulli N
Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
[TBL] [Abstract][Full Text] [Related]
15. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.
Sefton AK; Smith BJ; Stewart DA
J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551
[TBL] [Abstract][Full Text] [Related]
16. Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study.
Zhou C; Hovius SER; Slijper HP; Feitz R; Van Nieuwenhoven CA; Pieters AJ; Selles RW
Plast Reconstr Surg; 2015 Jul; 136(1):87-97. PubMed ID: 25829153
[TBL] [Abstract][Full Text] [Related]
17. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV
BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391
[TBL] [Abstract][Full Text] [Related]
18. Use of resources and costs associated with the treatment of Dupuytren's contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy.
Sanjuan Cerveró R; Franco Ferrando N; Poquet Jornet J
BMC Musculoskelet Disord; 2013 Oct; 14():293. PubMed ID: 24125161
[TBL] [Abstract][Full Text] [Related]
19. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
[TBL] [Abstract][Full Text] [Related]
20. Patient Preferences for Limited Fasciectomy Versus Collagenase Treatment for Dupuytren Contracture.
Zhang D; Blazar P; Benavent KA; Earp BE
J Hand Surg Asian Pac Vol; 2022 Apr; 27(2):242-247. PubMed ID: 35404200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
